Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831 · cited 1×
“, but it was subsequently discovered that they are powerful inhibitors of DNA methylation and induce gene expression and differentiation in cultured cell”
BackgroundSelf-citationThe power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Cytosine methylation and the ecology of intragenomic parasites
Yoder, J. A., Walsh, C. P., & Bestor, T. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01181-5 · Cited by 1,562
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
Takai, D., & Jones, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052410099 · Cited by 1,514
Self-citationKane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 1×
“However, MeCP2 might have a key role in the control of neuronal gene activity resulting in the pathology of Rett syndrome”
BackgroundX inactivation, differentiation, and DNA methylation
Riggs, A. D. (1975) · Cytogenetic and Genome Research · doi:10.1159/000130315 · Cited by 1,342
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Bunz, U. H. F. (2005) · Science · doi:10.1126/science.1111098 · Cited by 1,243
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,201
A histone H3 methyltransferase controls DNA methylation in Neurospora crassa
Tamaru, H., & Selker, E. U. (2001) · Nature · doi:10.1038/35104508 · Cited by 1,038
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 994
The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation
Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., & Kouzarides, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210256200 · Cited by 994
Establishment and Maintenance of a Heterochromatin Domain
Hall, I. M., Shankaranarayana, G. D., Noma, K.-I., Ayoub, N., Cohen, A., & Grewal, S. I. S. (2002) · Science · doi:10.1126/science.1076466 · Cited by 895
ARGONAUTE4 Control of Locus-Specific siRNA Accumulation and DNA and Histone Methylation
Zilberman, D., Cao, X., & Jacobsen, S. E. (2003) · Science · doi:10.1126/science.1079695 · Cited by 885
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
The many faces of histone lysine methylation
Lachner, M., & Jenuwein, T. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00335-6 · Cited by 819
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Reactivation of an Inactive Human X Chromosome: Evidence for X Inactivation by DNA Methylation
Mohandas, T., Sparkes, R. S., & Shapiro, L. J. (1981) · Science · doi:10.1126/science.6164095 · Cited by 709
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation
Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E., et al. (2001) · Nature Genetics · doi:10.1038/83730 · Cited by 694
Jüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
DNA Methylation Decreases in Aging But Not in Immortal Cells
Wilson, V. L., & Jones, P. A. (1983) · Science · doi:10.1126/science.6844925 · Cited by 645
Self-citationBinary switches and modification cassettes in histone biology and beyond
Fischle, W., Wang, Y., & David Allis, C. (2003) · Nature · doi:10.1038/nature02017 · Cited by 629
The SWI/SNF complex — chromatin and cancer
Roberts, C. W. M., & Orkin, S. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1273 · Cited by 603
Tufarelli, C., Stanley, J. A. S., Garrick, D., Sharpe, J. A., Ayyub, H., Wood, W. G., & Higgs, D. R. (2003) · Nature Genetics · doi:10.1038/ng1157 · Cited by 547 · cited 1×
“A recent report of a case of α-thalassaemia showed how antisense transcription could lead to DNA methylation and stable silencing of a globin gen”
BackgroundInhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
Self-citationDNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis
Soppe, W. J. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf657 · Cited by 500
Plumb, J. A., Strathdee, G. R., Sludden, J., Kaye, S. B., & Brown, R. E. (2000) · PubMed · doi:10.25405/ncl.34284429 · Cited by 486
Germline epimutation of MLH1 in individuals with multiple cancers
Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475
Interplay between Two Epigenetic Marks
Johnson, L. M., Cao, X., & Jacobsen, S. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00976-4 · Cited by 474
Imprinting in Prader–Willi and Angelman syndromes
Nicholls, R. D., Saitoh, S., & Horsthemke, B. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01432-2 · Cited by 450
Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J., Liang, G., & Jones, P. A. (2002) · PubMed · Cited by 444
Self-citationPremature ovarian failure in the fragile X syndrome
Sherman, S. L. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3<189::aid-ajmg1036>3.0.co;2-j · Cited by 437
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Prader-Willi syndrome: advances in genetics, pathophysiology and treatment
Goldstone, A. P. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.11.003 · Cited by 393
Linking the epigenetic ‘language’ of covalent histone modifications to cancer
Hake, S. B., Xiao, A., & Allis, C. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601575 · Cited by 385
Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., & Hornby, D. P. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00676-9 · Cited by 362
Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
Sato, N., Maitra, A., Fukushima, N., van Heek, N. T., Matsubayashi, H., Iacobuzio–Donahue, C. A., Rosty, C., & Goggins, M. (2003) · PubMed · Cited by 350
Marks, P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00084-5 · Cited by 344
Yamashita, K., Upadhyay, S., Osada, M., Hoque, M. O., Xiao, Y., Mori, M., Sato, F., Meltzer, S. J., & Sidransky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00215-5 · Cited by 340
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment
CONSTANTINIDES, P. G., JONES, P. A., & GEVERS, W. (1977) · Nature · doi:10.1038/267364a0 · Cited by 330
Self-citationInhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
Belinsky, S. A., Klinge, D. M., Stidley, C. A., Issa, J. J., Herman, J. G., March, T. H., & Baylin, S. B. (2003) · PubMed · Cited by 320
An Arabidopsis SET domain protein required for maintenance but not establishment of DNA methylation
Malagnac, F. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf687 · Cited by 313
Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S. W., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 311
Tariq, M., Saze, H., Probst, A. V., Lichota, J., Habu, Y., & Paszkowski, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432939100 · Cited by 310
CpG-Island Methylation in Aging and Cancer
Issa, J.-P. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_7 · Cited by 300
Beckwith-Wiedemann syndrome: imprinting in clusters revisited
Maher, E. R., & Reik, W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9340 · Cited by 297
Weber, J. S., Salgaller, M. L., Samid, D., Johnson, B., Herlyn, M., Lassam, N. J., Treisman, J. S., & Rosenberg, S. A. (1994) · PubMed · Cited by 294
5-Azacytidine, a new, highly effective cancerostatic
Šorm, F., Pískala, A., Čihák, A., & Veselý, J. (1964) · Experientia · doi:10.1007/bf02135399 · Cited by 286
Saunthararajah, Y., Hillery, C. A., Lavelle, D., Molokie, R., Dorn, L., Bressler, L., Gavazova, S., Chen, Y.-H., Hoffman, R., & DeSimone, J. (2003) · Blood · doi:10.1182/blood-2003-05-1738 · Cited by 277 · cited 1×
“In addition, azanucleosides are being tested for the treatment of haemoglobinopathie”
Reactivating the expression of methylation silenced genes in human cancer
Karpf, A. R., & Jones, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205602 · Cited by 264
Gazzoli, I., Loda, M. F., Garber, J. E., Syngal, S., & Kolodner, R. D. (2002) · PubMed · Cited by 249
Nguyen, C. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.22.4598 · Cited by 246
Molecular-clinical spectrum of the ATR-X syndrome
Gibbons, R. J., & Higgs, D. R. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3<204::aid-ajmg1038>3.0.co;2-x · Cited by 233
RNA and the Epigenetic Regulation of X Chromosome Inactivation
Panning, B., & Jaenisch, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81155-1 · Cited by 229
Liang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F., & Thykjær, T. (2002) · PubMed · Cited by 225
Self-citationLubbert, M., Wijermans, P., Kunzmann, R., Verhoef, G., Bosly, A., Ravoet, C., Andre, M., & Ferrant, A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02933.x · Cited by 224
Epigenetic targets in hematopoietic malignancies
Claus, R., & Lübbert, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206814 · Cited by 214
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Role of DNA Methylation in the Regulation of Cell Function: Autoimmunity, Aging and Cancer
Richardson, B. C. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2401s · Cited by 204
The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease
Ehrlich, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00201-8 · Cited by 203
Lin, X., Asgari, K., PUTZI, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., Marzo, A. M. D., et al. (2001) · PubMed · Cited by 180
Karpf, A. R., Moore, B. C., Ririe, T. O., & Jones, D. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09243-5 · Cited by 176
El-Osta, A., & Wolffe, A. P. (2001) · Gene Expression · doi:10.3727/000000001783992731 · Cited by 164
Studies of X chromosome DNA methylation in normal human cells
Wolf, S. F., & Migeon, B. R. (1982) · Nature · doi:10.1038/295667a0 · Cited by 147
Ginder, G. D., Whitters, M. J., & Pohlman, J. K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3954 · Cited by 137
Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity
Osaka, H., Mukherjee, P., Aisen, P. S., & Pasinetti, G. M. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990601)73:3<303::aid-jcb2>3.0.co;2-2 · Cited by 136
Xiao, H., Hasegawa, T., & Isobe, K.-I. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990601)73:3<291::aid-jcb1>3.0.co;2-5 · Cited by 131
Lan, Y., Nass, S. J., Smith, D., Nelson, W. G., Herman, J. G., & Davidson, N. E. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.469 · Cited by 96
MeCP2 Repression Goes Nonglobal
Klose, R., & Bird, A. (2003) · Science · doi:10.1126/science.1091762 · Cited by 95
Antisense RNA in imprinting: spreading silence through Air
Rougeulle, C., & Heard, É. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02749-x · Cited by 94
p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
Peterson, E. J., Bögler, O., & Taylor, S. M. (2003) · PubMed · Cited by 92
Syndromes of disordered chromatin remodeling
Ausió, J., Levin, D., De Amorim, G., Bakker, S., & Macleod, P. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00124.x · Cited by 90
Michalowsky, L. A., & Jones, P. A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.9.3076-3083.1987 · Cited by 78
Self-citationA Rheostat Model for a Rapid and Reversible Form of Imprinting-Dependent Evolution
Beaudet, A. L., & Jiang, Y. (2002) · The American Journal of Human Genetics · doi:10.1086/340969 · Cited by 74
Yang, A. S., Estecio, M. R. H., Garcia-Manero, G., Kantarjian, H. M., & Issa, J.-P. J. (2003) · Science · doi:10.1126/science.1089523 · Cited by 72
Soejima, H., Nakagawachi, T., Wei, Z., Higashimoto, K., Urano, T., Matsukura, S., Kitajima, Y., Takeuchi, M., Nakayama, M., Oshimura, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207576 · Cited by 58
Activation of an imprinted Igf 2 gene in mouse somatic cell cultures.
Eversole-Cire, P., Ferguson‐Smith, A. C., Sasaki, H., Brown, K. D., Cattanach, B. M., Gonzales, F. A., Surani, M. A., & Jones, P. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4928 · Cited by 58
Self-citationChromatin Modification, Leukaemia and Implications for Therapy
Jones, L. K., & Saha, V. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03586.x · Cited by 51
Carcinogenicity and haemoglobin synthesis induction by cytidine analogues
Carr, B., Rahbar, S., Asmeron, Y., Riggs, A., & Winberg, C. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.89 · Cited by 50
β-adrenergic receptor induction in HeLa cells: Synergistic effect of 5-azacytidine and butyrate
Jahangeer, S. M., Elliott, R. M., & Henneberry, R. C. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(82)80067-3 · Cited by 33
The X chromosome and fragile X mental retardation
Oostra, B. A., & Willemsen, R. (2002) · Cytogenetic and Genome Research · doi:10.1159/000071602 · Cited by 28
Cited by
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Self-citationWeber, M., Hellmann, I., Stadler, M. B., Ramos, L., Pääbo, S., Rebhan, M., & Schübeler, D. (2007) · Nature Genetics · doi:10.1038/ng1990 · Cited by 2,221
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.